Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,2,0.67 [0.55-0.81],4.14922484023334e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,2,0.69 [0.57-0.83],0.00011975549738128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD302,CD302 antigen,Inverse variance weighted,2,0.7 [0.58-0.85],0.000224030142044658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,2,0.73 [0.61-0.87],0.000464602238291368,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,2,0.73 [0.61-0.87],0.000503924656844171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,2,0.71 [0.58-0.86],0.000616757205381363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,2,0.72 [0.59-0.87],0.000754005420562336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.73 [0.6-0.88],0.000822382914284696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PCDH12,Protocadherin-12,Inverse variance weighted,2,1.39 [1.15-1.68],0.000830478196330681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,2,0.72 [0.6-0.88],0.000895586210629154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.72 [0.59-0.88],0.00107637964401658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,2,0.73 [0.61-0.88],0.00115593825115195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.73 [0.6-0.88],0.00141682460909217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.73 [0.6-0.89],0.00148371845193314,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,2,0.73 [0.6-0.89],0.0014891685810229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,2,0.73 [0.6-0.89],0.0015241278344224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,2,0.73 [0.6-0.89],0.00163037094236286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,2,0.77 [0.65-0.91],0.00164497974205909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,2,1.36 [1.12-1.66],0.00176367483912281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,OGN,Mimecan,Inverse variance weighted,2,0.77 [0.65-0.91],0.00214419235580418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,2,0.75 [0.62-0.91],0.00301525305363347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLMP,CXADR-like membrane protein,Inverse variance weighted,2,0.76 [0.63-0.91],0.00302017578404709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFNA1,Ephrin-A1,Inverse variance weighted,2,0.74 [0.61-0.91],0.00340346989960642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNASE6,Ribonuclease K6,Inverse variance weighted,2,0.76 [0.64-0.92],0.00376504337572362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDH1,Cadherin-1,Inverse variance weighted,2,0.75 [0.62-0.91],0.00379985397070259,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDHR1,Cadherin-related family member 1,Inverse variance weighted,2,1.35 [1.1-1.65],0.00383289001005768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NECTIN4,Nectin-4,Inverse variance weighted,2,0.75 [0.61-0.91],0.00440371497960386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.3 [1.08-1.57],0.00503285482379974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,2,0.76 [0.63-0.92],0.00523319567442631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Inverse variance weighted,2,0.76 [0.62-0.93],0.00727323036238644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,2,0.76 [0.62-0.93],0.00841363779555905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,2,0.77 [0.64-0.94],0.00858089251450879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HNMT,Histamine N-methyltransferase,Inverse variance weighted,2,0.8 [0.67-0.95],0.00953339941979569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.78 [0.64-0.94],0.0103986852961027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GDF15,Growth/differentiation factor 15,Inverse variance weighted,2,0.81 [0.69-0.95],0.0109891110310593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,2,0.78 [0.65-0.95],0.0116500788243276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PALM,Paralemmin-1,Inverse variance weighted,2,0.78 [0.64-0.95],0.0117931641312981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDSN,Corneodesmosin,Inverse variance weighted,2,0.7 [0.53-0.92],0.0119959712559763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD83,CD83 antigen,Inverse variance weighted,2,0.78 [0.64-0.95],0.0120999309565017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VWC2,Brorin,Inverse variance weighted,2,0.79 [0.66-0.95],0.0121557768181616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,2,0.78 [0.64-0.95],0.0139896672503194,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LMNB2,Lamin-B2,Inverse variance weighted,2,0.78 [0.64-0.95],0.014215691693404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SNCG,Gamma-synuclein,Inverse variance weighted,2,0.82 [0.71-0.96],0.0145699660577212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,2,0.83 [0.71-0.96],0.0156586485607551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,2,0.79 [0.65-0.96],0.0158128481575153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FSTL3,Follistatin-related protein 3,Inverse variance weighted,2,0.79 [0.65-0.96],0.0167184608194754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDH15,Cadherin-15,Inverse variance weighted,2,1.22 [1.04-1.44],0.0170731983631248,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,2,0.8 [0.67-0.96],0.0172770644893992,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,0.78 [0.63-0.96],0.0176495365413507,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PGF,Placenta growth factor,Inverse variance weighted,2,0.79 [0.65-0.96],0.0180732746265042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,2,0.82 [0.69-0.97],0.0192499515609023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,2,0.79 [0.66-0.96],0.0193792223647172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PALM2,Paralemmin-2,Inverse variance weighted,2,0.8 [0.66-0.97],0.0207539481095167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCN5,CCN family member 5,Inverse variance weighted,2,0.81 [0.68-0.97],0.0211387526746748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,2,0.8 [0.67-0.97],0.0212426840970602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,2,0.8 [0.66-0.97],0.0233673550525306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,2,0.85 [0.74-0.98],0.0241656122630376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,0.8 [0.66-0.97],0.0254487998722177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,2,0.81 [0.67-0.97],0.0254937260038195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,2,0.8 [0.66-0.97],0.0266112349380279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CFD,Complement factor D,Inverse variance weighted,2,0.8 [0.66-0.97],0.0266347599563558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,2,0.82 [0.69-0.98],0.026672089043595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,2,0.81 [0.68-0.98],0.0267680176708105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,2,0.8 [0.66-0.98],0.0291831504186948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,2,0.82 [0.68-0.98],0.030055893236366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.8 [0.66-0.98],0.0325949992738996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.83 [0.69-0.99],0.0339084660360557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,2,0.84 [0.71-0.99],0.034065198328321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RTN4R,Reticulon-4 receptor,Inverse variance weighted,2,0.81 [0.67-0.99],0.03439600421575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,2,0.81 [0.66-0.98],0.0346379198986606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,2,1.24 [1.01-1.52],0.0357246265723538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD160,CD160 antigen,Inverse variance weighted,2,0.81 [0.66-0.99],0.0358439476668874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,2,0.82 [0.68-0.99],0.0370620449774097,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTK7,Inactive tyrosine-protein kinase 7,Inverse variance weighted,2,0.78 [0.62-0.99],0.0374432324459727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,2,0.81 [0.67-0.99],0.0384751792894348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.74 [0.55-0.98],0.0389711179225208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTH,Parathyroid hormone,Inverse variance weighted,2,1.24 [1.01-1.51],0.0393893966313893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CTSV,Cathepsin L2,Inverse variance weighted,2,0.82 [0.69-0.99],0.0414158567189599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REG1A,Lithostathine-1-alpha,Inverse variance weighted,2,0.82 [0.68-0.99],0.0416141561718937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,2,0.82 [0.68-0.99],0.0422861326969215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,2,0.83 [0.69-0.99],0.0431252846265699,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPON2,Spondin-2,Inverse variance weighted,2,0.82 [0.67-0.99],0.0441792613707347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300C,CMRF35-like molecule 6,Inverse variance weighted,2,0.83 [0.69-1],0.0485076366514405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,2,0.83 [0.69-1],0.048569792823122,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PI3,Elafin,Inverse variance weighted,2,0.83 [0.69-1],0.0486581772210948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,2,1.21 [1-1.46],0.0493070067988568,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,2,0.83 [0.69-1],0.0495678224265895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,2,0.8 [0.64-1],0.0504363325980925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,1.22 [1-1.48],0.0529292852366836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,JAM3,Junctional adhesion molecule C,Inverse variance weighted,2,1.22 [1-1.5],0.0531843207153245,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.84 [0.71-1],0.0536275113307908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BAMBI,BMP and activin membrane-bound inhibitor homolog,Inverse variance weighted,2,1.22 [1-1.5],0.054585652176467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCN3,CCN family member 3,Inverse variance weighted,2,0.84 [0.7-1],0.0554161074757696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NPPC,C-type natriuretic peptide,Inverse variance weighted,2,0.83 [0.68-1],0.0555243081038298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,2,0.83 [0.68-1],0.0555666812879949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.83 [0.68-1],0.0557923191011229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,2,0.83 [0.69-1],0.0561314630182252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,2,0.84 [0.7-1.01],0.0582127955719142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,2,0.82 [0.67-1.01],0.059960070161804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,2,0.83 [0.68-1.01],0.060395014569386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,2,0.83 [0.69-1.01],0.0606999752675589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CA12,Carbonic anhydrase 12,Inverse variance weighted,2,0.83 [0.68-1.01],0.0612429592488507,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,2,0.83 [0.68-1.01],0.0615384782172466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,2,0.84 [0.7-1.01],0.0616237746746979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD7,T-cell antigen CD7,Inverse variance weighted,2,0.83 [0.69-1.01],0.0641205838424607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,2,0.83 [0.68-1.01],0.0643636526678959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD276,CD276 antigen,Inverse variance weighted,2,0.86 [0.73-1.01],0.0666203029073322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,2,0.83 [0.69-1.01],0.068543039207121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,2,0.84 [0.69-1.01],0.0689578330346466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300A,CMRF35-like molecule 8,Inverse variance weighted,2,0.84 [0.69-1.01],0.0690467262348584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,0.84 [0.7-1.01],0.0695400918271452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.83 [0.68-1.02],0.0703560504170724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,2,0.84 [0.69-1.02],0.0715390941909391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SDC1,Syndecan-1,Inverse variance weighted,2,0.84 [0.69-1.02],0.0717744000983737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BSG,Basigin,Inverse variance weighted,2,0.84 [0.69-1.02],0.0753713431233865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,2,1.24 [0.98-1.58],0.0756235666546781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,AMBP,Protein AMBP,Inverse variance weighted,2,0.84 [0.69-1.02],0.076003457867933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.84 [0.7-1.02],0.0771179535294806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,2,0.84 [0.7-1.02],0.0778905959248725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DLL1,Delta-like protein 1,Inverse variance weighted,2,0.84 [0.69-1.02],0.0797895260214617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CALCA,Calcitonin,Inverse variance weighted,2,0.85 [0.71-1.02],0.0827945160909243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,2,0.83 [0.68-1.02],0.0830055169735439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,2,0.85 [0.71-1.02],0.0851231785699865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,2,0.85 [0.7-1.02],0.0873552418744994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SEPTIN8,Septin-8,Inverse variance weighted,2,1.18 [0.98-1.44],0.087505604256278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ULBP2,UL16-binding protein 2,Inverse variance weighted,2,0.85 [0.71-1.02],0.0884161646307139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,2,0.85 [0.71-1.02],0.0891248722655353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TFF1,Trefoil factor 1,Inverse variance weighted,2,0.85 [0.71-1.03],0.0973567595639317,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.85 [0.69-1.03],0.0987100522071299,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGFBR1,TGF-beta receptor type-1,Inverse variance weighted,2,1.19 [0.97-1.46],0.09926685090844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,2,0.85 [0.7-1.03],0.103679436694614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.84 [0.69-1.04],0.104554750778775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,AREG,Amphiregulin,Inverse variance weighted,2,0.85 [0.7-1.04],0.107200089176754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CST3,Cystatin-C,Inverse variance weighted,2,0.86 [0.71-1.03],0.107933887546741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.85 [0.7-1.04],0.110430439705968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,2,0.85 [0.7-1.04],0.111100895107878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,2,0.87 [0.72-1.03],0.111394358831336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CHRDL1,Chordin-like protein 1,Inverse variance weighted,2,0.78 [0.57-1.06],0.113085722377296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,2,0.85 [0.7-1.04],0.11320836431855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,2,0.86 [0.71-1.04],0.113362250896962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LAYN,Layilin,Inverse variance weighted,2,0.86 [0.72-1.04],0.114663993340887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PCDH17,Protocadherin-17,Inverse variance weighted,2,1.16 [0.96-1.4],0.116392803209969,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD27,CD27 antigen,Inverse variance weighted,2,0.86 [0.71-1.04],0.121908984676081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,2,0.86 [0.71-1.04],0.122266541894696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,2,0.86 [0.71-1.04],0.122718213690217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GAST,Gastrin,Inverse variance weighted,2,0.86 [0.7-1.04],0.123247755777095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,2,0.86 [0.71-1.04],0.125245791511196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,2,0.87 [0.73-1.04],0.126394675765261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MMP3,Stromelysin-1,Inverse variance weighted,2,1.12 [0.97-1.29],0.129244513548607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,0.87 [0.73-1.04],0.129545223933229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REG1B,Lithostathine-1-beta,Inverse variance weighted,2,0.86 [0.72-1.04],0.131421633343802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LGALS1,Galectin-1,Inverse variance weighted,2,1.16 [0.96-1.41],0.131611602832265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TFF2,Trefoil factor 2,Inverse variance weighted,2,0.86 [0.71-1.05],0.134962032890536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,2,0.87 [0.72-1.05],0.13638206446261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.86 [0.7-1.05],0.136903137575749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,OCLN,Occludin,Inverse variance weighted,2,0.86 [0.71-1.05],0.141632981524809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,2,0.87 [0.71-1.05],0.142223177825134,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CX3CL1,Fractalkine,Inverse variance weighted,2,0.86 [0.71-1.05],0.142473377370835,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CTSL,Cathepsin L1,Inverse variance weighted,2,0.87 [0.71-1.05],0.143155245246035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ITGA11,Integrin alpha-11,Inverse variance weighted,2,0.86 [0.71-1.05],0.14485481545078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RTBDN,Retbindin,Inverse variance weighted,2,0.86 [0.71-1.05],0.146232228569482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDH3,Cadherin-3,Inverse variance weighted,2,0.83 [0.64-1.07],0.150208030138176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,2,0.87 [0.71-1.06],0.159669345724792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SHISA5,Protein shisa-5,Inverse variance weighted,2,0.87 [0.72-1.06],0.164521774200034,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,2,0.88 [0.73-1.06],0.165958141623781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.83 [0.64-1.08],0.166608503823625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,2,0.87 [0.71-1.06],0.169616725987191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ANXA10,Annexin A10,Inverse variance weighted,2,0.87 [0.71-1.06],0.17339326188772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,INHBB,Inhibin beta B chain,Inverse variance weighted,2,0.88 [0.72-1.06],0.177507971276824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PPL,Periplakin,Inverse variance weighted,2,1.15 [0.94-1.41],0.181060566875721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,2,1.19 [0.92-1.54],0.18211005766334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.82 [0.61-1.1],0.186259968275248,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,2,0.88 [0.74-1.06],0.187372964519473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TSHB,Thyrotropin subunit beta,Inverse variance weighted,2,1.14 [0.94-1.4],0.190482426732371,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,2,0.88 [0.72-1.07],0.190660265180862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MOG,Myelin-oligodendrocyte glycoprotein,Inverse variance weighted,2,0.88 [0.73-1.07],0.192921129405238,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,2,0.89 [0.74-1.06],0.193402136639633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Inverse variance weighted,2,0.88 [0.72-1.07],0.201814858494975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,0.88 [0.72-1.07],0.204744648476449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REN,Renin,Inverse variance weighted,2,0.88 [0.73-1.07],0.205969305890421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,2,0.9 [0.76-1.06],0.209446325792351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,2,0.9 [0.76-1.06],0.213281907437254,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,APOA2,Apolipoprotein A-II,Inverse variance weighted,2,0.88 [0.73-1.07],0.213573520861745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VASN,Vasorin,Inverse variance weighted,2,0.89 [0.73-1.07],0.214430357714255,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PGA4,Pepsin A-4,Inverse variance weighted,2,0.88 [0.73-1.08],0.217217140722324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,2,0.89 [0.74-1.07],0.221502217719577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCN4,CCN family member 4,Inverse variance weighted,2,0.89 [0.75-1.07],0.22176138112683,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CALB2,Calretinin,Inverse variance weighted,2,1.13 [0.93-1.39],0.222478185684166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EDN1,Endothelin-1,Inverse variance weighted,2,0.88 [0.73-1.08],0.226168890738767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,1.12 [0.93-1.35],0.227813259363816,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.89 [0.74-1.07],0.227993970401749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,2,1.13 [0.93-1.37],0.230389328468605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FBLN2,Fibulin-2,Inverse variance weighted,2,0.89 [0.73-1.08],0.230518591416578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,2,0.89 [0.73-1.08],0.236027548692773,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.89 [0.73-1.08],0.239384466020511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NECTIN2,Nectin-2,Inverse variance weighted,2,0.89 [0.73-1.08],0.240482322583212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,COLEC12,Collectin-12,Inverse variance weighted,2,0.9 [0.75-1.08],0.240877404228766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,2,0.84 [0.62-1.13],0.24855636238081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,2,0.9 [0.75-1.08],0.253613838073951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL16,C-C motif chemokine 16,Inverse variance weighted,2,0.91 [0.78-1.07],0.25475698606674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SEMA3F,Semaphorin-3F,Inverse variance weighted,2,0.89 [0.73-1.09],0.255625219925491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CALB1,Calbindin,Inverse variance weighted,2,0.89 [0.73-1.09],0.255773424876622,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,2,0.9 [0.75-1.08],0.258223541485943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ACTA2,"Actin, aortic smooth muscle",Inverse variance weighted,2,0.9 [0.75-1.08],0.258418732011276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,2,0.89 [0.73-1.09],0.258474193908055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PCDHB15,Protocadherin beta-15,Inverse variance weighted,2,1.11 [0.92-1.34],0.26517420530631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,2,0.93 [0.81-1.06],0.266985879498464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CFC1,Cryptic protein,Inverse variance weighted,2,1.12 [0.91-1.38],0.267471312199585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.91 [0.76-1.08],0.270870381944815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,2,0.9 [0.74-1.09],0.27235939956574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,2,0.91 [0.76-1.08],0.276323094835906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PLIN3,Perilipin-3,Inverse variance weighted,2,1.12 [0.91-1.37],0.278153264985307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.9 [0.75-1.09],0.281004651482731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,2,0.9 [0.75-1.09],0.286107921634674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,2,0.82 [0.56-1.19],0.294135778490773,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,2,0.9 [0.74-1.1],0.298549024221211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.91 [0.75-1.09],0.29887666506769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,B2M,Beta-2-microglobulin,Inverse variance weighted,2,0.88 [0.69-1.12],0.305086550521929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.11 [0.91-1.35],0.308429767623306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BGLAP,Osteocalcin,Inverse variance weighted,2,1.11 [0.91-1.35],0.308674931060311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,2,0.9 [0.74-1.1],0.31065841770895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,2,0.91 [0.75-1.09],0.310758562718953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,2,0.89 [0.72-1.11],0.310789390079208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,2,0.91 [0.75-1.1],0.321297752464302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ALCAM,CD166 antigen,Inverse variance weighted,2,0.91 [0.76-1.1],0.327543039986332,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.91 [0.75-1.1],0.330148038131637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DRAXIN,Draxin,Inverse variance weighted,2,0.91 [0.74-1.11],0.331223646025159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KLK11,Kallikrein-11,Inverse variance weighted,2,0.91 [0.75-1.1],0.332119881118051,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DPT,Dermatopontin,Inverse variance weighted,2,0.91 [0.75-1.1],0.334963219981696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MMP7,Matrilysin,Inverse variance weighted,2,0.91 [0.75-1.1],0.341610449845283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,2,0.91 [0.76-1.1],0.344736830149067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,2,0.91 [0.75-1.11],0.346484432277369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,2,0.9 [0.72-1.12],0.350790596532863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RSPO3,R-spondin-3,Inverse variance weighted,2,0.92 [0.76-1.1],0.351874591968778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GUCA2A,Guanylin,Inverse variance weighted,2,0.91 [0.75-1.11],0.35926058686696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,2,0.91 [0.73-1.12],0.367234205342982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,2,0.92 [0.76-1.11],0.38986662788692,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.88 [0.66-1.18],0.390374603908272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,2,0.92 [0.77-1.11],0.393747710185231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,2,0.92 [0.76-1.11],0.395293659866399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,2,0.92 [0.76-1.11],0.395332634632057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,2,0.89 [0.69-1.16],0.396972242585762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,2,0.91 [0.73-1.13],0.397227011534132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,2,0.92 [0.76-1.12],0.400061060624844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FOLR1,Folate receptor alpha,Inverse variance weighted,2,1.09 [0.9-1.31],0.400415509765197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL3,C-C motif chemokine 3,Inverse variance weighted,2,0.92 [0.77-1.11],0.4010901690544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,2,0.92 [0.76-1.12],0.404754932090181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,2,1.08 [0.9-1.3],0.404897732516525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.88 [0.66-1.19],0.407644093649089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,2,0.92 [0.77-1.11],0.407813383022947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.93 [0.78-1.11],0.414319972180178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,2,0.92 [0.75-1.12],0.417151558830012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,2,0.92 [0.76-1.12],0.41736239628199,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.08 [0.89-1.32],0.419177223295871,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,AGRN,Agrin,Inverse variance weighted,2,0.91 [0.73-1.14],0.424863204496571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,2,0.92 [0.76-1.12],0.425948443531759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,2,0.93 [0.77-1.12],0.4281606069777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NEFL,Neurofilament light polypeptide,Inverse variance weighted,2,1.07 [0.9-1.28],0.434960110375394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FABP6,Gastrotropin,Inverse variance weighted,2,0.92 [0.76-1.13],0.436073125277225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.08 [0.89-1.31],0.442090071004745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.93 [0.76-1.13],0.443366314204519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,2,1.08 [0.88-1.33],0.446412416943082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,2,0.92 [0.74-1.14],0.452183358228856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,2,1.08 [0.89-1.31],0.452551011507762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD59,CD59 glycoprotein,Inverse variance weighted,2,0.93 [0.77-1.12],0.452783890784049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRSS2,Trypsin-2,Inverse variance weighted,2,1.08 [0.88-1.31],0.467429003948553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,1.08 [0.88-1.31],0.469418024848305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VIT,Vitrin,Inverse variance weighted,2,0.94 [0.81-1.1],0.471219797291473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,2,0.93 [0.76-1.13],0.472048869923155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,2,0.93 [0.77-1.13],0.480176206369834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TFF3,Trefoil factor 3,Inverse variance weighted,2,0.93 [0.77-1.13],0.480851924885995,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MMP13,Collagenase 3,Inverse variance weighted,2,1.08 [0.88-1.32],0.485410953567128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL17C,Interleukin-17C,Inverse variance weighted,2,0.93 [0.76-1.14],0.498257883276024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,2,0.94 [0.78-1.13],0.499634360807994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,VGF,Neurosecretory protein VGF,Inverse variance weighted,2,1.07 [0.88-1.3],0.509474651961136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,2,0.95 [0.82-1.11],0.512675526851962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL17A,Interleukin-17A,Inverse variance weighted,2,0.93 [0.76-1.15],0.514832938998961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,XG,Glycoprotein Xg,Inverse variance weighted,2,0.95 [0.82-1.11],0.515252688144661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.06 [0.88-1.29],0.521383113865866,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL14,C-C motif chemokine 14,Inverse variance weighted,2,0.94 [0.78-1.14],0.522136334760986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL23,C-C motif chemokine 23,Inverse variance weighted,2,1.06 [0.88-1.28],0.523840140276587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.94 [0.78-1.13],0.527925207711371,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPP1,Osteopontin,Inverse variance weighted,2,1.06 [0.88-1.29],0.528345874977084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SEL1L,Protein sel-1 homolog 1,Inverse variance weighted,2,1.07 [0.87-1.3],0.529626115671401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,2,0.93 [0.73-1.17],0.529907054005207,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,2,1.05 [0.9-1.23],0.538152150353608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD300E,CMRF35-like molecule 2,Inverse variance weighted,2,0.94 [0.78-1.14],0.538476027225831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,2,0.94 [0.78-1.14],0.538509632984137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RETN,Resistin,Inverse variance weighted,2,0.92 [0.71-1.19],0.539905255691148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,2,1.06 [0.87-1.29],0.541234649746893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,2,0.94 [0.77-1.15],0.543971583831364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,2,0.94 [0.77-1.15],0.54633703448793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CTSZ,Cathepsin Z,Inverse variance weighted,2,0.94 [0.78-1.14],0.549068988201098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,2,0.94 [0.77-1.15],0.55094749819997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,2,0.95 [0.81-1.12],0.551436227500767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,2,0.94 [0.77-1.15],0.552407986041345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,2,0.94 [0.78-1.15],0.554997120379999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NRP2,Neuropilin-2,Inverse variance weighted,2,1.06 [0.87-1.28],0.556387151582136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,WNT9A,Protein Wnt-9a,Inverse variance weighted,2,1.06 [0.88-1.27],0.559755275599236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.94 [0.77-1.15],0.562966787307388,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,2,1.05 [0.88-1.26],0.56775395258082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,2,1.06 [0.87-1.28],0.57043214175736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,2,1.06 [0.87-1.29],0.570798220040788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SCG2,Secretogranin-2,Inverse variance weighted,2,0.94 [0.74-1.18],0.578599345119253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,2,1.05 [0.88-1.25],0.583479567631537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,2,0.95 [0.78-1.15],0.58647974299884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,UMOD,Uromodulin,Inverse variance weighted,2,0.96 [0.82-1.12],0.586693877953661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,2,0.92 [0.67-1.26],0.586722865728244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,STC2,Stanniocalcin-2,Inverse variance weighted,2,0.95 [0.78-1.15],0.603950057990228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,0.95 [0.78-1.16],0.616388491360083,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MDK,Midkine,Inverse variance weighted,2,0.95 [0.78-1.16],0.617249958302719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,2,1.05 [0.86-1.29],0.619898355432875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.95 [0.79-1.16],0.627488984258462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HSPB6,Heat shock protein beta-6,Inverse variance weighted,2,0.96 [0.8-1.14],0.62789648552959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,2,0.96 [0.8-1.15],0.629385850586597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,2,0.95 [0.79-1.16],0.639455089739661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL19,Interleukin-19,Inverse variance weighted,2,0.96 [0.79-1.16],0.653218285316837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ELN,Elastin,Inverse variance weighted,2,1.03 [0.89-1.2],0.653435609628711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,THBD,Thrombomodulin,Inverse variance weighted,2,0.96 [0.79-1.16],0.653540406452639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,2,0.96 [0.78-1.17],0.655863342933542,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,POF1B,Protein POF1B,Inverse variance weighted,2,1.05 [0.85-1.28],0.657620654106058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,KLK4,Kallikrein-4,Inverse variance weighted,2,0.97 [0.82-1.13],0.677770679302484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PDCD1,Programmed cell death protein 1,Inverse variance weighted,2,0.96 [0.79-1.17],0.695794694905537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL15,Interleukin-15,Inverse variance weighted,2,0.95 [0.75-1.22],0.704097511975071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD55,Complement decay-accelerating factor,Inverse variance weighted,2,0.96 [0.79-1.18],0.708472830030451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,2,0.96 [0.79-1.18],0.720525070120286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CYTL1,Cytokine-like protein 1,Inverse variance weighted,2,1.03 [0.87-1.23],0.721782537880919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TMSB10,Thymosin beta-10,Inverse variance weighted,2,1.04 [0.85-1.27],0.729360295086477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ITGAV,Integrin alpha-V,Inverse variance weighted,2,0.96 [0.77-1.2],0.739930275976956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,2,0.97 [0.81-1.17],0.754425773007344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RGMB,RGM domain family member B,Inverse variance weighted,2,1.03 [0.85-1.25],0.755241609771156,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,2,1.03 [0.83-1.29],0.758095155055976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DSC2,Desmocollin-2,Inverse variance weighted,2,0.97 [0.8-1.18],0.760026170925761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,2,1.03 [0.85-1.24],0.760469119386561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,2,1.03 [0.86-1.23],0.765910507327293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRL,Prolactin,Inverse variance weighted,2,0.97 [0.8-1.18],0.774462800282091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,2,0.98 [0.83-1.15],0.780600649210033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ACTN2,Alpha-actinin-2,Inverse variance weighted,2,0.97 [0.8-1.19],0.783739013146184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DKK4,Dickkopf-related protein 4,Inverse variance weighted,2,1.03 [0.84-1.25],0.784808907022182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MSMB,Beta-microseminoprotein,Inverse variance weighted,2,1.02 [0.89-1.17],0.785158433847993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,2,1.02 [0.87-1.2],0.785398768161888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,2,0.98 [0.82-1.16],0.79154373843921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,2,0.98 [0.81-1.18],0.797065799142156,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,2,0.98 [0.81-1.18],0.797850123282604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RSPO1,R-spondin-1,Inverse variance weighted,2,0.98 [0.8-1.19],0.802627223849979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,0.98 [0.8-1.19],0.812493143998963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CDH6,Cadherin-6,Inverse variance weighted,2,1.02 [0.86-1.22],0.813878155325741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LGALS9,Galectin-9,Inverse variance weighted,2,0.98 [0.82-1.17],0.822808447101836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,2,1.02 [0.83-1.26],0.829211220945051,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPON1,Spondin-1,Inverse variance weighted,2,0.98 [0.82-1.18],0.829790115812615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD46,Membrane cofactor protein,Inverse variance weighted,2,1.02 [0.84-1.25],0.831622428815608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,2,0.98 [0.8-1.19],0.831702424705293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,2,0.98 [0.81-1.18],0.832155449854232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PENK,Proenkephalin-A,Inverse variance weighted,2,0.98 [0.81-1.19],0.846542139192277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PSAP,Prosaposin,Inverse variance weighted,2,0.98 [0.81-1.19],0.862645809873455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,2,0.98 [0.81-1.2],0.869085740867611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,2,1.02 [0.83-1.24],0.869391526608479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,2,1.02 [0.83-1.24],0.870320163109692,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CA9,Carbonic anhydrase 9,Inverse variance weighted,2,1.02 [0.83-1.24],0.870658637149447,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DPY30,Protein dpy-30 homolog,Inverse variance weighted,2,1.02 [0.83-1.24],0.879919670509524,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CHGB,Secretogranin-1,Inverse variance weighted,2,1.02 [0.79-1.31],0.885587659716312,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,2,0.99 [0.82-1.19],0.894187450674428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,2,1.01 [0.82-1.25],0.898515609224684,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,THBS2,Thrombospondin-2,Inverse variance weighted,2,1.01 [0.84-1.22],0.900290076189143,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.99 [0.81-1.2],0.908924271754215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MB,Myoglobin,Inverse variance weighted,2,1.01 [0.85-1.2],0.91062327598682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.98 [0.72-1.33],0.910761551384661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CKB,Creatine kinase B-type,Inverse variance weighted,2,0.99 [0.81-1.21],0.913551019023508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CHGA,Chromogranin-A,Inverse variance weighted,2,0.99 [0.8-1.23],0.916930050839329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,2,1.01 [0.84-1.22],0.919174527867846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.01 [0.83-1.22],0.920649739273327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,RNASET2,Ribonuclease T2,Inverse variance weighted,2,1.01 [0.84-1.21],0.927590613304115,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CSTB,Cystatin-B,Inverse variance weighted,2,1.01 [0.85-1.2],0.931496050324546,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,2,0.99 [0.82-1.2],0.931894474323285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,2,0.99 [0.81-1.22],0.942463944006038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,LGALS4,Galectin-4,Inverse variance weighted,2,0.99 [0.83-1.19],0.945946693202639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.01 [0.83-1.23],0.948535103988202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MSLN,Mesothelin,Inverse variance weighted,2,1.01 [0.84-1.21],0.948676579737878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,2,0.99 [0.82-1.21],0.957578086579674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CD99,CD99 antigen,Inverse variance weighted,2,1 [0.84-1.18],0.961803347580191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,ANG,Angiogenin,Inverse variance weighted,2,1 [0.84-1.19],0.96921469846822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,MMP10,Stromelysin-2,Inverse variance weighted,2,1 [0.82-1.2],0.970243579712418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,PRSS8,Prostasin,Inverse variance weighted,2,1 [0.83-1.21],0.971271070310952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,2,1 [0.83-1.22],0.975697684179685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,CCL15,C-C motif chemokine 15,Inverse variance weighted,2,1 [0.85-1.18],0.990779339236462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,2,1 [0.84-1.19],0.992316766266702,trans
